Literature DB >> 29746174

Developmental regulation of kidney and liver solute carrier and ATP-binding cassette drug transporters and drug metabolizing enzymes: the role of remote organ communication.

Jeremiah D Momper1, Sanjay K Nigam2.   

Abstract

INTRODUCTION: The ontogeny of drug transport and metabolism is generally studied independently in tissues, yet in the immediate postnatal period the developmental regulation of SLC and ABC transporters and metabolizing enzymes must be coordinated. Using the Remote Sensing and Signaling Hypothesis as a framework, we describe how a systems physiology view helps to make sense of how inter-organ communication via hepatic, renal, and intestinal transporters and drug metabolizing enzymes (DMEs) is regulated from the immediate postnatal period through adulthood. Areas covered: This review examines patterns of developmental expression and function of transporters and DMEs with a focus on how cross-talk between these proteins in the kidney, liver and other organs (e.g., intestine) may be coordinated postnatally to optimize levels of metabolites and endogenous signaling molecules as well as gut-microbiome products. Expert opinion/commentary: Developmental expression is considered in terms of the Remote Sensing and Signaling Hypothesis, which addresses how transporters and DMEs participate in inter-organ and inter-organism small molecule communication in health, development, and disease. This hypothesis, for which there is growing support, is particularly relevant to the 'birth transition' and post-natal developmental physiology when organs must deal with critical physiological tasks distinct from the fetal period and where remote inter-organ and possibly inter-organismal (e.g. infant-gut microbiome) communication is likely to be critical to maintain homeostasis.

Entities:  

Keywords:  Drug metabolism; development; ontogeny; transport

Mesh:

Substances:

Year:  2018        PMID: 29746174      PMCID: PMC6277044          DOI: 10.1080/17425255.2018.1473376

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  82 in total

Review 1.  Biochemical and molecular pharmacological aspects of transporters as determinants of drug disposition.

Authors:  Yoshimichi Sai
Journal:  Drug Metab Pharmacokinet       Date:  2005-04       Impact factor: 3.614

2.  MATURATION OF RENAL FUNCTION IN CHILDHOOD: CLEARANCE STUDIES.

Authors:  M I Rubin; E Bruck; M Rapoport; M Snively; H McKay; A Baumler
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808

Review 3.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

4.  Ontogeny of novel cytochrome P450 gene isoforms during postnatal liver maturation in mice.

Authors:  Julia Yue Cui; Helen J Renaud; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2012-03-23       Impact factor: 3.922

5.  Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice.

Authors:  Jonathan M Maher; Angela L Slitt; Nathan J Cherrington; Xingguo Cheng; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2005-03-31       Impact factor: 3.922

6.  The impact of plasma protein binding on the renal transport of organic anions.

Authors:  Daniel A J Bow; Jennifer L Perry; John D Simon; John B Pritchard
Journal:  J Pharmacol Exp Ther       Date:  2005-09-29       Impact factor: 4.030

7.  Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1).

Authors:  William R Wikoff; Megha A Nagle; Valentina L Kouznetsova; Igor F Tsigelny; Sanjay K Nigam
Journal:  J Proteome Res       Date:  2011-04-22       Impact factor: 4.466

8.  The integration of allometry and virtual populations to predict clearance and clearance variability in pediatric populations over the age of 6 years.

Authors:  Andrea N Edginton; Bhavank Shah; Michael Sevestre; Jeremiah D Momper
Journal:  Clin Pharmacokinet       Date:  2013-08       Impact factor: 6.447

9.  Hepatocyte nuclear factors 4α and 1α regulate kidney developmental expression of drug-metabolizing enzymes and drug transporters.

Authors:  Gleb Martovetsky; James B Tee; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2013-09-13       Impact factor: 4.436

10.  Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes.

Authors:  Wei Wu; Kevin T Bush; Sanjay K Nigam
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

View more
  7 in total

1.  Dynamics of Organic Anion Transporter-Mediated Tubular Secretion during Postnatal Human Kidney Development and Maturation.

Authors:  Jeremiah D Momper; Jin Yang; Mary Gockenbach; Florin Vaida; Sanjay K Nigam
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-18       Impact factor: 8.237

Review 2.  Membrane transporters in traumatic brain injury: Pathological, pharmacotherapeutic, and developmental implications.

Authors:  Fanuel T Hagos; Solomon M Adams; Samuel M Poloyac; Patrick M Kochanek; Christopher M Horvat; Robert S B Clark; Philip E Empey
Journal:  Exp Neurol       Date:  2019-02-21       Impact factor: 5.330

3.  Intestinal breast cancer resistance protein (BCRP) requires Janus kinase 3 activity for drug efflux and barrier functions in obesity.

Authors:  Jayshree Mishra; Randall Simonsen; Narendra Kumar
Journal:  J Biol Chem       Date:  2019-10-25       Impact factor: 5.157

4.  Insights into the structure and function of the human organic anion transporter 1 in lipid bilayer membranes.

Authors:  Angelika Janaszkiewicz; Ágota Tóth; Quentin Faucher; Marving Martin; Benjamin Chantemargue; Chantal Barin-Le Guellec; Pierre Marquet; Florent Di Meo
Journal:  Sci Rep       Date:  2022-04-29       Impact factor: 4.996

5.  Rosinidin Protects against Cisplatin-Induced Nephrotoxicity via Subsiding Proinflammatory and Oxidative Stress Biomarkers in Rats.

Authors:  Sadaf Jamal Gilani; May Nasser Bin-Jumah; Fahad A Al-Abbasi; Muhammad Shahid Nadeem; Sami I Alzarea; Mohammed Muqtader Ahmed; Nadeem Sayyed; Imran Kazmi
Journal:  Int J Environ Res Public Health       Date:  2022-08-07       Impact factor: 4.614

6.  Drosophila SLC22 Orthologs Related to OATs, OCTs, and OCTNs Regulate Development and Responsiveness to Oxidative Stress.

Authors:  Darcy C Engelhart; Priti Azad; Suwayda Ali; Jeffry C Granados; Gabriel G Haddad; Sanjay K Nigam
Journal:  Int J Mol Sci       Date:  2020-03-15       Impact factor: 5.923

Review 7.  Drug-Induced Nephrotoxicity Assessment in 3D Cellular Models.

Authors:  Pengfei Yu; Zhongping Duan; Shuang Liu; Ivan Pachon; Jianxing Ma; George P Hemstreet; Yuanyuan Zhang
Journal:  Micromachines (Basel)       Date:  2021-12-21       Impact factor: 2.891

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.